New York State Common Retirement Fund’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Hold
27,540
﹤0.01% 2468
2026
Q1
$124K Hold
27,540
﹤0.01% 2434
2025
Q4
$169K Hold
27,540
﹤0.01% 2362
2025
Q3
$199K Hold
27,540
﹤0.01% 2295
2025
Q2
$146K Sell
27,540
-120,429
-81% -$711K ﹤0.01% 2386
2025
Q1
$1.31M Hold
147,969
﹤0.01% 1536
2024
Q4
$2.03M Buy
147,969
+16,249
+12% +$300K ﹤0.01% 1413
2024
Q3
$3.61M Sell
131,720
-8,000
-6% -$217K ﹤0.01% 1216
2024
Q2
$3.42M Buy
139,720
+2,067
+2% +$45.4K ﹤0.01% 1283
2024
Q1
$2.93M Buy
137,653
+5,769
+4% +$124K ﹤0.01% 1318
2023
Q4
$2.52M Sell
131,884
-241
-0.2% -$4.17K ﹤0.01% 1368
2023
Q3
$2.12M Buy
132,125
+218
+0.2% +$4.15K ﹤0.01% 1428
2023
Q2
$3.06M Buy
131,907
+5,135
+4% +$112K ﹤0.01% 1349
2023
Q1
$2.94M Sell
126,772
-38,933
-23% -$791K ﹤0.01% 1380
2022
Q4
$2.4M Sell
165,705
-677,809
-80% -$12.6M ﹤0.01% 1537
2022
Q3
$16.1M Buy
843,514
+18,063
+2% +$415K 0.02% 624
2022
Q2
$15M Buy
825,451
+73,216
+10% +$1.52M 0.02% 683
2022
Q1
$19M Buy
752,235
+1,783
+0.2% +$45.6K 0.02% 660
2021
Q4
$20.7M Sell
750,452
-124,552
-14% -$3.61M 0.02% 645
2021
Q3
$28.3M Sell
875,004
-10,175
-1% -$338K 0.03% 508
2021
Q2
$27.1M Sell
885,179
-142,198
-14% -$4.11M 0.03% 538
2021
Q1
$31.3M Sell
1,027,377
-72,218
-7% -$2.05M 0.03% 467
2020
Q4
$21.7M Buy
1,099,595
+242,931
+28% +$3.92M 0.02% 602
2020
Q3
$11.2M Hold
856,664
0.01% 797
2020
Q2
$9.71M Sell
856,664
-60,652
-7% -$861K 0.01% 877
2020
Q1
$13.1M Buy
917,316
+2,224
+0.2% +$47K 0.02% 677
2019
Q4
$24.9M Sell
915,092
-17,971
-2% -$494K 0.03% 563
2019
Q3
$26.7M Buy
933,063
+799,928
+601% +$23.3M 0.03% 513
2019
Q2
$3.7M Hold
133,135
﹤0.01% 1376
2019
Q1
$4.42M Sell
133,135
-10,751
-7% -$327K 0.01% 1299
2018
Q4
$4.18M Sell
143,886
-26,551
-16% -$955K 0.01% 1263
2018
Q3
$7.84M Sell
170,437
-43,477
-20% -$1.93M 0.01% 1101
2018
Q2
$7.99M Buy
213,914
+2,900
+1% +$98K 0.01% 1101
2018
Q1
$6.24M Hold
211,014
0.01% 1156
2017
Q4
$7.25M Buy
211,014
+2,343
+1% +$79K 0.01% 1115
2017
Q3
$7.55M Sell
208,671
-27,207
-12% -$776K 0.01% 1066
2017
Q2
$6.09M Buy
235,878
+2,799
+1% +$59.4K 0.01% 1187
2017
Q1
$4.47M Buy
233,079
+85,396
+58% +$1.51M 0.01% 1302
2016
Q4
$2.46M Sell
147,683
-12,220
-8% -$221K ﹤0.01% 1583
2016
Q3
$3.29M Sell
159,903
-121,062
-43% -$3.07M ﹤0.01% 1411
2016
Q2
$8.6M Sell
280,965
-21,335
-7% -$741K 0.01% 1004
2016
Q1
$11.3M Buy
302,300
+21,225
+8% +$800K 0.02% 848
2015
Q4
$12.1M Sell
281,075
-38,360
-12% -$1.62M 0.02% 814
2015
Q3
$12M Buy
319,435
+300
+0.1% +$10.6K 0.02% 803
2015
Q2
$10.8M Buy
319,135
+44,360
+16% +$1.51M 0.02% 882
2015
Q1
$9.73M Buy
274,775
+184,475
+204% +$6.6M 0.01% 893
2014
Q4
$3.08M Buy
+90,300
New +$3.2M ﹤0.01% 1427
2014
Q3
Sell
-230,000
Closed -$8.95M 2055
2014
Q2
$8.95M Hold
230,000
0.01% 987
2014
Q1
$7.86M Hold
230,000
0.01% 1033
2013
Q4
$4.83M Sell
230,000
-282,850
-55% -$7.15M 0.01% 1242
2013
Q3
$12.1M Buy
512,850
+20,000
+4% +$568K 0.02% 797
2013
Q2
$13.2M Buy
+492,850
New +$14.3M 0.02% 692

Other funds holding MYGN

New York State Common Retirement Fund's MYGN Position: Q2 2026 in Review

New York State Common Retirement Fund held its Myriad Genetics (MYGN) position steady in Q2 2026 at 27,540 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

New York State Common Retirement Fund first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.3M in Q1 2021. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • New York State Common Retirement Fund held 27,540 shares of Myriad Genetics worth $157K as of Q2 2026.
  • New York State Common Retirement Fund left its Myriad Genetics share count unchanged in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2468 holding.
  • New York State Common Retirement Fund first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
  • New York State Common Retirement Fund's Myriad Genetics position peaked at $31.3M in Q1 2021.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.